FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to an immune-inducing composition containing polypeptide MCEMP1 with an amino acid sequence with SEQ ID NO: 2 or 8; it can be used in medicine.
EFFECT: obtained composition can be used for the effective therapy of MCEMP1-expressing cancer.
6 cl, 3 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
| IMMUNITY INDUCER | 2016 |
|
RU2835947C2 |
| IMMUNITY INDUCER | 2016 |
|
RU2758112C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMORS | 2017 |
|
RU2755894C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR | 2017 |
|
RU2766586C2 |
| PEPTIDE DERIVED FROM FOXM1, AND INCLUDING ITS VACCINE | 2016 |
|
RU2738418C2 |
| IMMUNE TOLERANCE INDUCING ANTIBODIES, INDUCED LYMPHOCYTES AND THERAPEUTIC AGENT/METHOD OF CELL THERAPY USING INDUCED LYMPHOCYTES | 2019 |
|
RU2816592C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR | 2019 |
|
RU2781542C2 |
| ANTIBODY TO HUMAN CD73 | 2017 |
|
RU2754058C2 |
